9 Mar
2021

Covid-19 patent landscape confusion is a big concern for life sciences organisations

New data is beginning to shed light on covid-19-related IP filings, but major patent landscape uncertainties pose dangers for research organisations and access to medicine

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth